Jeffrey Shaw jshaw at
Sat May 30 16:31:02 BRT 1998

We have used GABBRIOMYCINA to treat cases of anergic diffuse cutaneous
leishmaniasis (ADCL) caused by Leishmania (Leishmania) amazonensis. There
was a definite clinical improvement but the cure was not definitive. The
response was progressively poorer when the treatment was repeated.

Auditory secondary complications were detected. 

More information about the Leish-l mailing list